在患有神经发育障碍的儿童中,双甲和甲酸代谢
T Peter Stein1, Margaret D Schluter1, Robert A Steer2
1Department of Surgery, Rowan University-School of Osteopathic Medicine, Stratford, NJ, United States of America.
患有自闭症谱系 (ASD) 和注意力缺陷/多动症 (ADHD) 的儿童显示,可塑剂双-A (BPA) 和二甲基甲酸盐 (DEHP) 的排毒减少. 与对照组相比,BPA排毒在ASD和ADHD组中效率明显低.
科学领域:
- 环境健康 环境健康
- 发育儿科 发育儿科
- 代谢学 代谢学 代谢学
背景情况:
- 自闭症谱系障碍 (ASD) 和注意力缺陷/多动障碍 (ADHD) 有复杂的病因.
- 流行病学研究将环境污染物,包括像Bisphenol-A (BPA) 和Diethylhexyl Phthalate (DEHP) 这样的塑化剂,与ASD和ADHD联系起来.
- 葡萄糖化是BPA和DEHP分泌的主要途径,增加了消除的水溶性.
研究的目的:
- 与健康对照组相比,研究在被诊断为ASD和ADHD的儿童中葡萄糖化疗法的效率.
- 为了确定BPA和DEHP的排毒途径是否在ASD和ADHD的儿童中受到损害.
主要方法:
- 从三个组收集尿样:ASD (n=66),ADHD (n=46) 和健康对照组 (CTR,n=37).
- 利用质谱和完整的代谢组分析来评估12个途径的葡萄化效率.
- 专门测量了BPA和MEHP (DEHP代谢物) 的葡萄化效率.
主要成果:
- 代谢组分析显示,三组之间存在显著的代谢差异.
- 对于BPA和DEHP,葡萄糖化途径是唯一有效地区分这些组的途径.
- 与对照组相比,在ASD (11%降低,p=0.020) 和ADHD (17%降低,p<0.001) 的儿童中,BPA葡萄化效率显著降低. 德赫普 (DEHP) 显示了类似的趋势,尽管在统计学上并不显著.
结论:
- 患有自闭症和多动症的儿童表现出不同的临床和代谢特征.
- 无论是ASD和ADHD组,在BPA和DEHP的排毒中都有一个共同的障碍.
- 在统计学上显著的减少BPA排毒效率突出显示了潜在的环境因素,有助于ASD和ADHD的发病.
更多相关视频
08:28Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
Published on: April 26, 2018
06:46Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production
Published on: June 2, 2023
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Inborn Errors of Metabolism
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
The drug's acidity or basicity is essential in...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
